1260619-37-1 Usage
General Description
(S)-tert-butyl 5-methyl-1,4-diazepane-1-carboxylate is a chemical compound with a molecular formula of C11H21NO2. It is a cyclic ester derivative of tert-butyl carbamate and is commonly used in pharmaceutical synthesis. (S)-tert-butyl 5-methyl-1,4-diazepane-1-carboxylate is often utilized as a reagent in organic chemistry reactions, and its stable tert-butyl group makes it a valuable building block for creating various complex molecules. The 5-methyl-1,4-diazepane ring in the compound provides structural flexibility and potential for diverse applications in medicinal chemistry and drug design. Its unique structure and properties make it a valuable tool for drug discovery and development efforts.
Check Digit Verification of cas no
The CAS Registry Mumber 1260619-37-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,6,1 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1260619-37:
(9*1)+(8*2)+(7*6)+(6*0)+(5*6)+(4*1)+(3*9)+(2*3)+(1*7)=141
141 % 10 = 1
So 1260619-37-1 is a valid CAS Registry Number.
1260619-37-1Relevant articles and documents
A method for synthesizing intermediate su wolei lives
-
, (2019/07/05)
The invention provides a su wolei lives intermediate (5 S) - hexahydro - 5 - methyl - 1 H - 1, 4 - benzodiazepine - 1 - carboxylic acid tert-butyl synthetic method, comprises the following steps: (1) compound Suvor - 1 red aluminum solution reaction, to o
Laboratory and practical synthesis of Suvorexant, a selective dual orexin receptor antagonist
Minehira, Daisuke,Takahara, Satoyuki,Adachi, Isao,Toyooka, Naoki
supporting information, p. 5778 - 5780 (2014/12/11)
The development of a laboratory and practical synthesis of Suvorexant 1, using intramolecular Mitsunobu cyclization reaction of intermediate 5 as the key reaction, has been reported. Compound 5 was obtained from known chiral ester 2 in three steps, and the key cyclization proceeded smoothly to provide the core seven-membered ring compound 6, which was transformed into 1 by an additional four-step sequence. The procedure described here needs no chiral-HPLC separation, no classical resolution, and no unique enzyme reactions, and offers an alternative practical synthesis of 1.
